GelStat Corp. (GSAC)

0.0004 0.0000 (0.00%) At close: 11:08AM EDT

GelStat Corp.

3557 SW Corporate Parkway
Palm City, FL 34990
United States
772-283-0020
https://www.gelstat.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 2

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Javier G. Acosta	CEO & Director	N/A	N/A	N/A
Mr. Charles F. Tarzian	Chief Marketing Advisor	N/A	N/A	1957
Dr. Roger K. Cady M.D.	Chief Medical Advisor	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation was founded in 2002 and is headquartered in Palm City, Florida.

Corporate governance

GelStat Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.